Arizona Tribune - Technology

NYSE - LSE

RYCEF	0.1%	20.83	$
RIO	3.73%	100.44	$
BTI	-0.71%	55.98	$
BCE	1.43%	23.7	$
BCC	3.55%	83.13	$
RBGPF	0.5%	69.35	$
RELX	1.68%	35.1	$
CMSC	0.27%	21.298	$
GSK	3.27%	52.88	$
VOD	0.25%	16.17	$
CMSD	0.28%	21.15	$
NGG	-1.85%	80.66	$
BP	0.73%	43.73	$
AZN	2.94%	164.95	$
JRI	-0.48%	12.38	$

Featured

Robots sort packages and serve fast food at Beijing showcase

Robots sorting parcels and serving fried chicken enthralled visitors at a robotics expo in Beijing on Wednesday, where hundreds of companies set out their pitches for a future labour market transformed by artificial intelligence.

Europe can't afford to miss AI revolution: ECB chief

European Central Bank chief Christine Lagarde said Wednesday that the continent could not afford to miss out on the artificial intelligence revolution as the continent's growth model comes under increasing pressure.

Last news

Innodata to Report Fourth Quarter and Fiscal Year 2025 Results

NEW YORK, NY / ACCESS Newswire / February 5, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Fourth Quarter and Fiscal Year 2025 results after the market closes on Thursday, February 26, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com.

HEICO Corporation Completes EthosEnergy Accessories and Components Acquisition

Expands HEICO into Aeroderivative Gas Turbine Parts

Rain Enhancement Technologies Expands Research into Air Quality and Smog Mitigation

New Research Initiative to Test if Ionization Can Remove Harmful Particles From the Atmosphere Before People Breathe Them

Conga Recognized in the 2026 Gartner Magic Quadrant for Configure, Price and Quote Applications

Evaluation based on completeness of vision and ability to execute

Nixtla Raises $16 Million Series A To Advance Time Series Intelligence and Agentic Forecasting

The funding backs continued innovation in production-grade forecasting, anomaly detection, and artificial intelligence.

Water Tower Research Highlights Mirle Partnership Fueling Ainos' Robotics Scale-Up and SmellTech Expansion

AI Nose integration positions robotics application as a scalable growth engineMirle partnership expands SmellTech robotics into industrial environments

ParkerVision Files Opening Brief for its Expedited Appeal in ParkerVision v. Qualcomm

JACKSONVILLE, FL / ACCESS Newswire / February 5, 2026 / ParkerVision, Inc. ("the Company") (OTCQB:PRKR), a leader in wireless radio-frequency (RF) innovation, announced the filing of its opening brief to the Court of Appeals for the Federal Circuit ("CAFC") in its appeal of the district court decision in ParkerVision v. Qualcomm in the Middle District of Florida. A copy of the Company's opening brief can be found here.

Nextech3D.ai to Report Q3 2025 Earnings After Market Close on February 18, 2026

TORONTO, ON / ACCESS Newswire / February 5, 2026 / Nextech3D.ai (OTCQB:NEXCF)(CSE:NTAR)(FSE:1SS), an AI-first technology company focused on enterprise event technology, immersive engagement, and experiential solutions, today announced that it will release its financial results for the third quarter ended December 31, 2025 after the close of business on Wednesday, February 18, 2026.

Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM

Omisirge transplantation shows accelerated immune recovery in SAANew data presented at the 2026 TANDEM Meetings demonstrate that patients with SAA who received Omisirge experienced faster and more robust immune recovery compared with patients receiving alternative transplant graft sourcesOmisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic AnemiaKey Highlights of Data Presented at TANDEM:Rapid neutrophil recovery: Median time to neutrophil engraftment was 10 days following Omisirge transplantation. Faster recovery was associated with higher transplanted CD34⁺ cell dosesEnhanced CD4⁺T-cell reconstitution: At six months post-transplant, CD4⁺ T-cell counts were significantly higher in Omisirge recipients compared with other transplant sources including matched and haploidentical donors. Higher CD4⁺ T-cell recovery correlated with more rapid neutrophil engraftmentAccelerated NK-cell recovery: Natural killer (NK) cell reconstitution occurred early after transplant, with median NK-cell counts at days 30 and 100 exceeding those observed across all comparator graft sourcesOmisirge approved by the FDA on December 5, 2025 for SAA

Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026

Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue.Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024.The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million.

Whack-a-mole: US academic fights to purge his AI deepfakes

As deepfake videos of John Mearsheimer multiplied across YouTube, the American academic rushed to have them taken down, embarking on a grueling fight that laid bare the challenges of combating AI-driven impersonation.

CORRECTION FROM SOURCE: Expert Intelligence Raises $5.8 Million Seed Round to Bring AI Decision Automation to Regulated Laboratories

Updated funding amount

iTacit Forecasts Workforce Enablement Trends for 2026

The frontline-first workforce technology company predicts five trends in how organizations will respond to challenges of slow, fragmented, and ineffective training systems.

New Report from The Modern Data Company Finds the Data Activation Gap Is Holding Back Enterprise AI and Decision-Making

The Modern Data Report 2026 reveals that 68% of data practitioners say their data isn't reliable enough for AI, and 87% say better data (trusted, contextual, and easily accessible across teams) would improve decision speed.

CuriosityStream Declares Quarterly Cash Dividend

Dividend supported by continued and recurring free cash flow generation and expanding AI-driven data licensing activities

ProScore Technologies Announces Strategic Partnership with Qcells to Support Compliance and Workforce Management for Utility-Scale Clean Energy Projects

AI-Powered Platform to Serve as System of Record for Compliance Across Qcells' U.S. Project Development and Construction Activities

Candescent and Greenlight Partner to Build the Next Generation of Financially Empowered Families

Collaboration enables banks and credit unions with a powerful way to offer families lifelong money skills, and grow loyalty for generations

Preservica Redefines Digital Preservation with Powerful Built-In AI Tools

OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow.

ATREYD'S Secures $44.9 Million Security Contract to Protect Strategic Energy Infrastructure with Autonomous, Unmanned Defense Systems

Deal includes delivery of new CIRCEE Unmanned Surface Vessels, reflecting the growing need to defend critical infrastructure against modern, asymmetric threats

enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Company achieves minimum $1.00 closing bid for 10 consecutive business days; Nasdaq confirms matter is closedReports Cash and Investments of approximately $28 million as of the Year Ended December 31, 2025

CAVU Resources, Inc. (OTC:CAVR) Provides Update on Timeline for Proposed Merger with Post Bid Ship, Inc.

TULSA, OKLAHOMA / ACCESS Newswire / February 4, 2026 / CAVU Resources, Inc. ("CAVR" or the "Company"), OTC, today issued an update regarding the timeline for its proposed spin-out and merger with Post Bid Ship, Inc. and PBS Recon, Inc.

Datametrex Expands Business In Data Centres

TORONTO, ONTARIO / ACCESS Newswire / February 4, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce the continued expansion of its business into modern data centre operations & infrastructure solutions business. As part of this expansion, the Company is deploying Nutanix-based hyperconverged infrastructure (HCI) solutions, which unify servers, storage, and networking into a single, integrated platform designed to enhance operational stability, scalability, processing speed, and capacity efficiencies. Currently, the company has had good success deploying in South Korea with these solutions. These solutions have had stronger performance than traditional based VMware products. The company looks to rollout these specific solutions in North America.

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

GelrinC, the only restorative product for knee cartilage repair, has CE Mark approval in Europe and is currently at the midpoint of a pivotal FDA Phase III trial in the U.S.Ori Gon brings substantial public company, medtech, and capital markets experience

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant)

Bebuzee ($BBUZ) Sets the Stage for Global Push with Strategic Series of Super App Updates

MIAMI, FL / ACCESS Newswire / February 4, 2026 / Bebuzee Inc. ($BBUZ), the rapidly evolving next-generation super app company, today announced a strategic sequence of major platform updates scheduled over the next three consecutive release windows - this weekend, next weekend, and again in two weeks - designed to prime the platform for an expanded global push.

Expert Intelligence Raises $4.7M Seed Round to Automate Expert Judgment in Regulated Labs

SANTA CLARA, CA / ACCESS Newswire / February 4, 2026 / Expert Intelligence™, a startup building AI systems that automate expert decision-making in regulated laboratory environments, today announced it has raised a $4.7M seed round led by Sierra Ventures with participation from TSVC and Acorn Pacific Ventures.

GameSquare Appoints Amaree Tanawong as Chief Operating Officer

Tanawong brings nearly two decades of experience scaling strategy, monetization, and operational platforms across YouTube, Meow Wolf, Fullscreen, and Yahoo

Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value Creation

AI Nose advances through a dual-engine architecture, enabling scalable deploymentsIndustrial and semiconductor deployments broaden Ainos' commercial footprintRobotics momentum accelerates data flywheel growth and commercial scale-up in 2026

Nextech3D.ai Expands Krafty Lab Enterprise Engagement Platform with F-35 Flight Simulation Experiences Through The Squadron Partnership

Partnership with The Squadron Introduces High-Fidelity Flight Simulation for Enterprise Leadership Development, Executive Offsites and Premium Engagement Programs

Ayrmid Reports Additional New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease and Beta-Thalassemia

Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% (11 of 15) of patients were able to collect sufficient HSC to enable progress to gene therapy manufacturing with 5 patients receiving their gene therapy and appropriately engrafted73% (11 of 15) of patients had previously failed to collect sufficient cells with plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSC for people with sickle cell disease and in combination with G-CSF for beta-thalassemiaFindings presented at TANDEM 2026

iBLOXX Secures USD 5.4 Million for Global Launch of StrayShot

iBLOXX Studios DMCC has raised USD 5.4 million to finalize development and support the global launch of its mobile-first third-person shooter, StrayShot. Based in Dubai and part of the DMCC Gaming Centre and Dubai Program for Gaming 2033, the studio collaborates with partners like the Dubai Future Foundation and Xsolla. StrayShot features multiple modes (Battle Royale, Team Deathmatch, Extraction), is optimized for low-end devices, and is set in the fictional region of Sierra Verde. Currently in closed testing, the game will include blockchain-enabled asset ownership. The funding will fuel global marketing, live operations, ongoing updates, and future console versions.

Seven Oshyn Experts Honored with 2026 Sitecore Most Valuable Professional Awards

Seven specialists recognized for their technical mastery and strategic leadership within the global Sitecore ecosystem.

Arizona Tribune - Technology (English)